Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
Ahmed Hassan Fahal, Eiman Siddig Ahmed, Sahar Mubarak Bakhiet, Osama Elhadi Bakhiet, Lamis Ahmed Fahal, Abubakar Ahmed Mohamed, El Semani Widaa Mohamedelamin, Mustafa El Nour Bahar, Hadil Yassir Attalla, Emmanuel Edwar Siddig, Najwa A. Mhmoud, Ahmed Musa, Wendy W. J. van de Sande, Bruno Scherrer, Peelen Oyieko, Thaddaeus Egondi, Kevin Onyango, Katsura Hata, Wan‐Yu Chu, Thomas P. C. Dorlo, Roger J. M. Brüggemann, Borna Nyaoke, Nathalie Strub‐Wourgaft, Eduard E. Zijlstra
Topics & Concepts
MedicineItraconazoleDouble blindProof of conceptInternal medicineTraditional medicineSurgeryDermatologyPlaceboAntifungalAlternative medicinePathologyComputer scienceOperating systemActinomycetales infections and treatmentInfectious Diseases and MycologyFungal Infections and Studies